Mutares, the Munich-based investment firm specializing in turnarounds, has announced the acquisition of Hyva’s crane division from JOST Werke in a deal worth approximately €100 million in annual revenue. The transaction, expected to close in Q4 2025, aligns with Mutares’ strategy of revitalizing underperforming business units. The crane division, which employs 400 workers and operates production facilities in Italy, Brazil, and China, has faced recent financial challenges—presenting an opportunity for Mutares to leverage its restructuring expertise.
Market Reaction and Strategic Shift
Both Mutares and JOST Werke saw positive stock movements following the announcement, with Mutares shares rising 2.17%. For JOST, the sale allows a sharper focus on core operations, while Mutares integrates the division into its Goods & Services segment. The acquisition underscores Mutares’ growth strategy, targeting niche markets with turnaround potential. Financial terms remain undisclosed, but the deal is pending regulatory approvals.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from January 3 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 3.
Mutares: Buy or sell? Read more here...
